ESWL Versus ESWL and Endoscopic Treatment
Unknown statusNot applicableNCT02971475
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
The study wants to compare ESWL alone with ESWL and endoscopic drainage of the MPD for treatment of pain in chronic pancreatitis.
Study details
- Official title
- Extracorporeal Shock Wave Lithotripsy Versus Extracorporeal Shock Wave Lithotripsy Combined With Endoscopic Treatment for Painful Calcified Chronic Pancreatitis
- Conditions
- Pancreatitis
- Interventions
- Procedure: extracorporeal shock wave lithotripsy
- Procedure: endoscopic drainage of the main pancreatic duct
- Drug: Analgesics
- Sponsor
- Changhai Hospital
- Start date
- 2016-11
- Primary completion
- 2019-05
- Sex
- All
- Age range
- from 18 Years
- Results posted
- No results posted in this snapshot
- Countries
- China
- Total sites listed
- 2
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * painful chronic pancreatitis(abdominal pain attack during the preceding 12 months); * at least 1 calcified stone greater than 5 mm in one of its axes in the cephalic or corporeal portion of the main pancreatic duct with upstream duct dilation; * no ERCP or ESWL carried out before admission Exclusion Criteria: * suspected to have malignant tumors; * history of pancreatic surgery or gastrojejunostomy (Billroth II); * pancreatic collection greater than 2 cm in diameter at magnetic resonance or CT scan; * age below 18 years; * pregnancy or lactation; * refuse to write informed consent
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT02971475